XML 107 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
VARIABLE INTEREST ENTITIES (Tables)
3 Months Ended
Mar. 31, 2013
Debt Instrument [Line Items]  
Schedule of Unconsolidated VIE
The following table presents the carrying amounts of the assets in the Company's consolidated balance sheets that relate to the Company's variable interests in identified non-consolidated VIEs and the Company's maximum exposure to loss associated with these VIEs in which it holds variable interests at March 31, 2013 (in thousands):
 
Receivables from
Managed Entities and
Related Parties,
Net (1)
 
Investments
 
Maximum Exposure
to Loss in
Non-consolidated VIEs
RRE Opportunity REIT
$

 
$
2,242

 
$
2,242

Trapeza entities

 
956

 
956

Ischus entities
184

 

 
184

 
$
184

 
$
3,198

 
$
3,382

Gross unrealized loss and fair value of securities
Unrealized losses, along with the related fair values and aggregated by the length of time the investments were in a continuous unrealized loss position, are as follows (in thousands, except number of securities):
 
Less than 12 Months
 
More than 12 Months
 
Fair Value
 
Unrealized
Loss
 
Number of Securities
 
Fair Value
 
Unrealized
Loss
 
Number of Securities
March 31, 2013:
 
 
 
 
 
 
 
 
 
 
 
CLO securities
$
949

 
$
(217
)
 
1

 
$

 
$

 

Allowance for loan losses and recorded investments
The following table summarizes the activity in the allowance for credit losses for all financing receivables (in thousands):
(Restated)
Receivables
from Managed
Entities
 
Leases and Loans
 
Rent
Receivables
 
Total
Three Months Ended March 31, 2013:
 
 
 
 
 
 
 
Balance, beginning of year
$
32,560

 
$

 
$
68

 
$
32,628

Provision for (reversal of) credit losses
330

 
(3
)
 
11

 
338

Charge-offs

 

 
(25
)
 
(25
)
     Recoveries
16

 
3

 

 
19

Balance, end of period
$
32,906

 
$

 
$
54

 
$
32,960

 
 
 
 
 
 
 
 
Ending balance, individually evaluated for impairment
$
32,906

 
$

 
$

 
$
32,906

Ending balance, collectively evaluated for impairment

 

 
54

 
54

Balance, end of period
$
32,906

 
$

 
$
54

 
$
32,960

 
 
 
 
 
 
 
 
Three Months Ended March 31, 2012:
 
 
 
 
 
 
 
Balance, beginning of year
$
12,575

 
$

 
$
29

 
$
12,604

Provision for (reversal of) credit losses
2,963

 
(6
)
 
5

 
2,962

     Recoveries

 
6

 

 
6

Balance, end of period
$
15,538

 
$

 
$
34

 
$
15,572

 
 
 
 
 
 
 


Ending balance, individually evaluated for impairment
$
15,538

 
$

 
$

 
$
15,538

Ending balance, collectively evaluated for impairment

 

 
34

 
34

Balance, end of period
$
15,538

 
$

 
$
34

 
$
15,572

Loan portfolios aging analysis
The following table is the aging of the Company’s past due financing receivables (presented gross of allowance for credit losses) as of March 31, 2013 (in thousands):
(Restated)
30-89 Days
Past Due
 
Greater than
90 Days
 
Greater than
181 Days
 
Total
Past Due
 
Current
 
Total
Receivables from managed entities
    and related parties: (1)
 
 
 
 
 
 
 
 
 
 
 
Commercial finance investment entities
$

 
$

 
$
39,887

 
$
39,887

 
$
93

 
$
39,980

Real estate investment entities
1,140

 
679

 
16,368

 
18,187

 
2,245

 
20,432

Financial fund management entities
18

 

 
15

 
33

 
2,269

 
2,302

Other
21

 

 

 
21

 
100

 
121

 
1,179

 
679

 
56,270

 
58,128

 
4,707

 
62,835

Rent receivables - real estate
7

 
12

 
42

 
61

 
51

 
112

Total financing receivables
$
1,186

 
$
691

 
$
56,312

 
$
58,189

 
$
4,758

 
$
62,947

 
(1)
Receivables are presented gross of an allowance for credit losses of $32.4 million and $457,000 related to the Company’s commercial finance and financial fund management investment entities.  The remaining receivables from managed entities and related parties have no related allowance for credit losses.
    
The following table is the aging of the Company’s past due financing receivables (presented gross of allowance for credit losses) as of December 31, 2012 (in thousands):
(Restated)
30-89 Days
Past Due
 
Greater than
90 Days
 
Greater than
181 Days
 
Total
Past Due
 
Current
 
Total
Receivables from managed entities
   and related parties: (1)
 
 
 
 
 
 
 
 
 
 
 
Commercial finance investment entities
$

 
$

 
$
40,112

 
$
40,112

 
$
118

 
$
40,230

Real estate investment entities
779

 
744

 
17,062

 
18,585

 
1,992

 
20,577

Financial fund management entities
6

 

 
47

 
53

 
2,140

 
2,193

Other
41

 

 

 
41

 
137

 
178

 
826

 
744

 
57,221

 
58,791

 
4,387

 
63,178

Rent receivables - real estate
4

 
10

 
58

 
72

 
40

 
112

Total financing receivables
$
830

 
$
754

 
$
57,279

 
$
58,863

 
$
4,427

 
$
63,290

 
(1)
Receivables are presented gross of an allowance for credit losses of $29.6 million, $2.5 million and $457,000 related to the Company’s commercial finance, real estate and financial fund management investment entities, respectively.  The remaining receivables from managed entities and related parties had no related allowance for credit losses.
Impaired loans
The following table discloses information about the Company’s impaired financing receivables (in thousands):
(Restated)
Net
Balance
 
Unpaid Balance
 
Specific Allowance
 
Average
Investment in
 Impaired
Assets
As of March 31, 2013
 
 
 
 
 
 
 
Financing receivables with a specific valuation allowance:
 

 
 

 
 

 
 

Receivables from managed entities – commercial finance
$
5,744

 
$
38,193

 
$
32,449

 
$
38,129

Receivables from managed entities – financial fund management
848

 
1,305

 
457

 
1,305

Rent receivables – real estate

 
54

 
54

 
45

 
 
 
 
 
 
 
 
As of December 31, 2012
 
 
 
 
 
 
 
Financing receivables with a specific valuation allowance:
 

 
 

 
 

 
 

Receivables from managed entities – commercial finance
$
8,633

 
$
38,219

 
$
29,586

 
$
38,110

Receivables from managed entities – real estate
2,291

 
4,808

 
2,517

 
4,630

Receivable from managed entities - financial fund management
848

 
1,305

 
457

 
1,305

Rent receivables – real estate

 
68

 
68

 
40

Schedule of Debt
The credit facilities and other debt of the Company and related borrowings outstanding are as follows (in thousands): 
 
As of March 31, 2013
 
December 31, 2012
(Restated)
Maximum Amount
of Facility
 
Borrowings Outstanding
 
Borrowings Outstanding
Credit facilities:
 

 
 

 
 
TD Bank – secured revolving credit facility (1) 
$
6,997

 
$

 
$

Republic Bank – secured revolving credit facility
3,500

 

 

 
 

 

 

Other Debt:
 
 
 
 
 
Senior Notes
 

 
10,000

 
10,000

Mortgage debt
 

 
10,425

 
10,473

Other debt
 

 
321

 
567

Total borrowings
 

 
$
20,746

 
$
21,040

 
(1)
The amount of the facility as shown has been reduced for the outstanding letter of credit of $503,000 at March 31, 2013 and December 31, 2012.
Fair value assets and liabilities measured on recurring basis
As of March 31, 2013, the fair values of the Company’s assets recorded at fair value on a recurring basis were as follows (in thousands): 
(Restated)
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Investment securities
$
364

 
$

 
$
9,457

 
$
9,821

As of December 31, 2012, the fair values of the Company’s assets recorded at fair value on a recurring basis were as follows (in thousands): 
(Restated)
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Investment securities
$
209

 
$

 
$
10,367

 
$
10,576

Fair value assets unobservable input reconciliation
The following table presents additional information about assets which were measured at fair value on a recurring basis for which the Company has utilized Level 3 inputs to determine fair value during the three months ended March 31, 2013 (in thousands):
(Restated)
Investment Securities
Balance, beginning of year
$
10,367

Purchases
3,404

Income accreted
227

Payments and distributions received
(2,719
)
Impairment recognized in earnings
(214
)
Sales
(2,460
)
Gain on sales of trading securities
517

Unrealized holding gain on trading securities
745

Change in unrealized losses included in accumulated other comprehensive loss
(410
)
Balance, end of period
$
9,457

Fair value assets and liabilities measured on nonrecurring basis
The Company recognized the following changes in carrying value of the assets and liabilities measured at fair value on a non-recurring basis, as follows (in thousands):
 
Level 1
 
Level 2
 
Level 3
 
Total
Three Months Ended March 31, 2013:
 
 
 
 
 
 
 
Asset:
 
 
 
 
 
 
 
Receivables from managed entities – commercial finance, real estate and financial fund management
$

 
$

 
$
7,313

 
$
7,313

Liability:
 

 
 

 
 

 
 

Apidos contractual commitment
$

 
$

 
$
994

 
$
994

 
 
 
 
 
 
 
 
Year Ended December 31, 2012:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Receivables from managed entities – commercial finance and real estate
$

 
$

 
$
14,506

 
$
14,506

Investment in real estate

 
727

 

 
727

Investment in real estate - office building

 

 
906

 
906

Investment in CVC Credit Partners

 

 
28,600

 
28,600

Investment in Apidos-CVC preferred interest

 

 
6,792

 
6,792

Total
$

 
$
727

 
$
50,804

 
$
51,531

Liability:
 

 
 

 
 

 
 

Apidos contractual commitment
$

 
$

 
$
589

 
$
589

Fair value financial instruments not reported at fair value
The fair value of financial instruments required to be disclosed at fair value, excluding instruments valued on a recurring basis, is as follows (in thousands):
 
March 31, 2013
 
December 31, 2012
(Restated)
Carrying Amount
 
Estimated Fair Value
 
Carrying Amount
 
Estimated Fair Value
Assets:
 
 
 
 
 
 
 
Receivables from managed entities
$
29,929

 
$
29,929

 
30,618

 
30,618

 
$
29,929

 
$
29,929

 
$
30,618

 
$
30,618

Borrowings:
 

 
 

 
 

 
 

Real estate debt
$
10,425

 
$
11,616

 
$
10,473

 
$
11,398

Senior Notes
10,000

 
12,066

 
10,000

 
11,728

Other debt
321

 
321

 
567

 
567

 
$
20,746

 
$
24,003

 
$
21,040

 
$
23,693

Resource Capital Corp [Member]
 
Debt Instrument [Line Items]  
Condensed Financial Statements
The following reflects the detail of the assets and liabilities and operations of RSO, which the Company consolidated and included in its consolidated balance sheets and statements of operations.
RSO Balance Sheet detail (in thousands):
 
March 31, 2013
 
December 31, 2012
 
(Unaudited)
 
 
ASSETS (1)
 
 
 
Cash and cash equivalents
$
67,661

 
$
85,278

Restricted cash
112,131

 
94,112

Subtotal- Cash and cash equivalents
179,792

 
179,390

 
 
 
 
Investment securities, trading
32,892

 
24,843

Investment securities available-for-sale, pledged as collateral, at fair value
192,673

 
195,200

Investment securities available-for-sale, at fair value
49,609

 
36,390

Subtotal- Investments, at fair value
275,174

 
256,433

 
 
 
 
Loans held for sale
18,150

 
48,894

Loans, pledged as collateral and net of allowances of $17.0 million and $17.7 million
1,708,540

 
1,793,780

Loans receivable–related party
7,860

 
8,324

Subtotal - Loans before eliminations
1,734,550

 
1,850,998

Eliminations
(1,570
)
 
(1,570
)
Subtotal - Loans
1,732,980

 
1,849,428

 
 
 
 
Investment in real estate
75,142

 
75,386

Investments in unconsolidated entities
48,419

 
45,413

Subtotal - Investments in real estate and unconsolidated entities before eliminations
123,561

 
120,799

Eliminations
(108
)
 
(93
)
Subtotal - Investments in real estate and unconsolidated entities
123,453

 
120,706

 
 
 
 
Linked transactions, net at fair value
22,455

 
6,835

Interest receivable
8,913

 
7,763

Deferred tax asset
2,887

 
2,766

Principal paydown receivable
20

 
25,570

Intangible assets
12,660

 
13,192

Prepaid expenses
3,839

 
10,396

Other assets
4,712

 
4,109

Subtotal - Other assets before eliminations
$
55,486

 
$
70,631

Eliminations
(32
)
 
(31
)
Subtotal - Other assets
$
55,454

 
$
70,600

 
 
 
 
Total assets - before eliminations
$
2,368,563

 
$
2,478,251

Total assets - after eliminations
$
2,366,853

 
$
2,476,557

LIABILITIES (2)


 
 

Borrowings
$
1,649,840

 
$
1,785,600

 
 
 
 
Distribution payable
22,731

 
21,655

Accrued interest expense
3,096

 
2,918

Derivatives, at fair value
14,036

 
14,687

Accrued tax liability
1,859

 
13,641

Deferred tax liability
8,376

 
8,376

Accounts payable and other liabilities
10,877

 
18,029

Subtotal - other liabilities before eliminations
60,975

 
79,306

Eliminations
(2,311
)
 
(8,067
)
Subtotal - Other liabilities
58,664

 
71,239

Total liabilities - before eliminations
$
1,710,815

 
$
1,864,906

Total liabilities - after eliminations
$
1,708,504

 
$
1,856,839

The following table presents the details of noncontrolling interests attributable to RSO (in thousands):
 
March 31,
2013
 
December 31,
2012
 
(Unaudited)
 
 
Total stockholders' equity per RSO balance sheet
$
657,748

 
$
613,345

Eliminations
(31,432
)
 
(31,022
)
Noncontrolling interests attributable to RSO
$
626,316

 
$
582,323


RSO Balance Sheet detail (in thousands):
 
March 31,
2013
 
December 31,
2012
 
(Unaudited)
 
 
(1) Assets of consolidated VIEs of RSO included in the total assets above:
 
 
 
        Restricted cash
$
107,620

 
$
90,108

        Investments securities available-for-sale, pledged as collateral, at fair value
137,553

 
135,566

        Loans held for sale
18,150

 
14,894

        Loans, pledged as collateral and net of allowances of $13.3 million
           and $15.2 million
1,533,796

 
1,678,719

        Interest receivable
6,527

 
5,986

        Prepaid expenses
303

 
328

        Principal receivable
21

 
25,570

        Other assets

 
333

        Total assets of consolidated RSO VIEs
$
1,803,970

 
$
1,951,504

 
 
 
 
(2) Liabilities of consolidated VIEs of RSO included in the total liabilities above:
 
 
 
        Borrowings
$
1,475,014

 
$
1,614,882

        Accrued interest expense
2,528

 
2,666

        Derivatives, at fair value
13,478

 
14,078

        Accounts payable and other liabilities
1,423

 
698

        Total liabilities of consolidated RSO VIEs
$
1,492,443

 
$
1,632,324

RSO Income Statement Detail
(in thousands)
 
Three Months Ended
 
March 31,
 
2013
 
2012
 
(Unaudited)
 
(Unaudited)
REVENUES
 
 
 
Interest income:
 
 
 
Loans
$
27,812

 
$
23,615

Securities
3,642

 
3,405

Interest income − other
1,866

 
2,829

Total interest income
33,320

 
29,849

Interest expense
11,165

 
8,383

Net interest income
22,155

 
21,466

Rental income
6,174

 
1,919

Dividend income
16

 
17

Equity in losses of unconsolidated subsidiaries
(425
)
 
1,071

Fee income
1,410

 
1,610

Net realized and unrealized gain on sales of investment securities
available-for-sale and loans
391

 
380

Net realized and unrealized (loss) gain on investment securities, trading
1,116

 
2,144

Unrealized gain (loss) and net interest income on linked transactions, net
(259
)
 
119

Revenues from consolidated VIE - RSO
30,578

 
28,726

OPERATING EXPENSES
 

 
 

Management fees − related party
2,978

 
3,443

Equity compensation − related party
3,591

 
868

Professional services
1,446

 
1,100

Insurance
162

 
158

Rental operating expense
3,937

 
1,320

General and administrative
1,873

 
1,063

Depreciation and amortization
1,138

 
1,361

Income tax expense
1,762

 
2,615

Net impairment losses recognized in earnings
21

 
139

Provision for loan losses
1,042

 
2,178

Total operating expenses
17,950

 
14,245

Reclassification of income tax provision
(1,762
)
 
(2,615
)
Expenses from consolidated VIE -RSO
16,188

 
11,630

Adjusted operating income
14,390

 
17,096

OTHER REVENUE (EXPENSE)
 

 
 

Income from continuing operations
14,390

 
17,096

Income tax provision - RSO
1,762

 
2,615

NET INCOME
12,628

 
14,481

Net income allocated to preferred shares
(1,311
)
 

Net income allocated to noncontrolling interests
209

 

NET INCOME ALLOCABLE TO RSO COMMON SHARES
$
11,526

 
$
14,481

RSO Summarized Cash Flow Detail
(in thousands)
 
Three Months Ended
 
March 31,
 
2013
 
2012
CASH FLOWS FROM OPERATING ACTIVITIES:
(Unaudited)
 
(Unaudited)
Net income
$
12,628

 
$
14,481

Line items included in "Change in cash attributable to consolidated VIE - RSO":
 
 
 
Provision for loan losses
1,042

 
2,178

Depreciation of investments in real estate and other
666

 
380

Amortization of intangible assets
532

 
982

Amortization of term facilities
221

 
140

Accretion of net discounts on loans held for investment
(4,079
)
 
(5,519
)
Accretion of net discounts on securities available-for-sale
(731
)
 
(861
)
Amortization of discount on notes of CDOs
876

 
308

Amortization of debt issuance costs on notes of CDOs
1,176

 
927

Amortization of stock-based compensation
3,591

 
868

Amortization of terminated derivative instruments
55

 
56

Distribution to subordinated debt holder
670

 
1,584

Accretion of interest-only available-for-sales securities
(247
)
 

Deferred income tax benefit
(115
)
 

Purchase of securities, trading
(10,044
)
 
(8,348
)
Principal payments on securities, trading
21

 
833

Proceeds from sales of securities, trading
3,089

 
5,025

Net realized and unrealized gains on investment securities, trading
(1,116
)
 
(2,144
)
Net realized gain on sales of investment securities available-for-sale and loans
(391
)
 
(380
)
Net impairment losses recognized in earnings
12

 
139

Linked transactions fair value adjustments
592

 

Equity in losses (earnings) of unconsolidated subsidiaries
425

 
(1,071
)
Changes in operating assets and liabilities
14,426

 
(14,761
)
Subtotal - net cash provided by operating activities
10,671

 
(19,664
)
Change in consolidated VIE - RSO cash for the period
17,617

 
5,554

Subtotal - Change in cash attributable to operations of consolidated VIE - RSO before eliminations
28,288

 
(14,110
)
Elimination of intercompany activity
(654
)
 
1

Subtotal - Change in cash attributable to operations of consolidated VIE - RSO
27,634

 
(14,109
)
 
 
 
 
Non-cash incentive compensation to RAI
(1
)
 
165

Elimination of intercompany activity
1

 
(165
)
Non-cash incentive compensation to RAI - after eliminations

 

 
 
 
 
Net cash provided by (used in) operating activities (excluding eliminations)
23,298

 
(5,018
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended
 
March 31,
 
2013
 
2012
CASH FLOWS FROM INVESTING ACTIVITIES:
(Unaudited)
 
(Unaudited)
Purchase of loans
(146,699
)
 
(150,845
)
Purchase of securities available-for-sale
(63,292
)
 
(16,660
)
Subtotal - purchase of loans and investment securities by consolidated VIE - RSO
(209,991
)
 
(167,505
)
Proceeds from sale of loans
58,148

 
40,120

Principal payments received on loans
209,107

 
116,848

Principal payments on securities available-for-sale
7,944

 
5,595

Principal payments received on loans – related parties
464

 
69

Subtotal - principal payments and proceeds from sale of loans and securities by consolidated VIE - RSO
275,663

 
162,632

Decrease in restricted cash
(19,241
)
 
9,196

Lines included in "Other - consolidated VIE - RSO":
 
 
 
Investment in unconsolidated entity
(4,431
)
 
934

Improvements in real estate held-for-sale

 
(138
)
Proceeds from sale of real estate held-for-sale

 
907

Distributions from investments in real estate
253

 
448

Improvements in investments in real estate
(321
)
 
(348
)
Purchase of furniture and fixtures

 
(722
)
Subtotal - other investing activities of consolidated VIE - RSO, before eliminations
(4,499
)
 
1,081

Eliminations

 
20

Subtotal - other investing activities of consolidated VIE
(4,499
)
 
1,101

Net cash provided by investing activities (excluding eliminations)
41,932

 
5,404

 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
Items included in "Net borrowings (repayments) of debt by consolidated VIE - RSO":
 
 
 
Proceeds from borrowings:
 
 
 

   Repurchase agreements
37,145

 
8,948

Payments on borrowings:
 
 
 

   Collateralized debt obligations
(141,341
)
 
(18,485
)
Net repayments of debt by consolidated VIE - RSO
(104,196
)
 
(9,537
)
Distributions paid on common stock
(20,978
)
 
(19,979
)
Elimination of RAI dividends received
556

 
505

Distributions paid on RSO common stock, after eliminations
(20,422
)
 
(19,474
)
Items included in "Net proceeds from issuance of stock by consolidated VIE - RSO":
 
 
 
Net proceeds from dividend reinvestment and stock purchase plan (net of offering costs of $0 and $19)
17,995

 
24,158

Proceeds from issuance of 8.25% Series B redeemable
preferred shares (net of offering costs of $707 and $0)
26,867

 

Subtotal - Net proceeds from issuance of stock by consolidated VIE - RSO
44,862

 
24,158

Items included in "Other - consolidated VIE - RSO":
 
 
 
Payment of debt issuance costs
(140
)
 
(582
)
Payment of equity to third party sub-note holders
(1,461
)
 

Distributions paid on preferred stock
(934
)
 

Subtotal - Other consolidated VIE - RSO financing activity
(2,535
)
 
(582
)
Net cash used in financing activities (excluding eliminations)
$
(82,847
)
 
$
(5,940
)
NET INCREASE IN CASH AND CASH EQUIVALENTS
(17,617
)
 
(5,554
)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
85,278

 
43,116

CASH AND CASH EQUIVALENTS AT END OF PERIOD
$
67,661

 
$
37,562

SUPPLEMENTAL DISCLOSURE:
 
 
 
Interest expense paid in cash
$
10,188

 
$
8,401

Real property useful lives
RSO depreciates real property using the straight-line method over the estimated useful lives of the assets as follows:
Category
Term
Building
25 – 40 years
Site improvements
Lesser of the remaining life of building or useful lives
Schedule of Variable Interest Entities
The following table shows the classification and carrying value of assets and liabilities of consolidated RSO VIEs as of March 31, 2013 (in thousands):
 
Apidos I
 
Apidos
III
 
Apidos
Cinco
 
Apidos
VIII
 
Whitney CLO I
 
RREF
2006
 
RREF
2007
 
Total
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted cash (1)
$
41,833

 
$
8,546

 
$
26,439

 
$
13,241

 
$
16,832

 
$
19

 
$
710

 
$
107,620

Investment securities
available-for-sale, pledged as
collateral, at fair value
7,904

 
6,321

 
11,618

 
955

 
33,906

 
10,950

 
65,899

 
137,553

Loans, pledged as collateral
140,141

 
187,390

 
306,837

 
320,144

 
113,700

 
188,853

 
276,731

 
1,533,796

Loans held for sale
1,378

 
2,228

 

 
13,800

 
744

 

 

 
18,150

Interest receivable
9

 
798

 
1,176

 
871

 
423

 
1,153

 
2,097

 
6,527

Prepaid assets
39

 
24

 
32

 
56

 
68

 
48

 
36

 
303

Principal receivable
12

 

 
9

 

 

 

 

 
21

Other assets

 

 

 

 

 

 

 

Total assets (2)
$
191,316

 
$
205,307

 
$
346,111

 
$
349,067

 
$
165,673

 
$
201,023

 
$
345,473

 
$
1,803,970

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIABILITIES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Borrowings
$
174,493

 
$
193,248

 
$
320,699

 
$
321,182

 
$
149,939

 
$
116,220

 
$
199,233

 
$
1,475,014

Accrued interest expense
346

 
82

 
321

 
1,372

 
234

 
52

 
121

 
2,528

Derivatives, at fair value

 

 

 

 

 
1,908

 
11,570

 
13,478

Accounts payable and
other liabilities
140

 
16

 
32

 
384

 
837

 
13

 
1

 
1,423

Total liabilities
$
174,979

 
$
193,346

 
$
321,052

 
$
322,938

 
$
151,010

 
$
118,193

 
$
210,925

 
$
1,492,443

                            
(1)    Includes $35.7 million available for reinvestment in certain of the CDOs.
(2)    Assets of each of the consolidated VIEs may only be used to settle the obligations of each respective VIE.
The following table shows the classification, carrying value and maximum exposure to loss with respect to RSO’s unconsolidated VIEs as of March 31, 2013 (in thousands):
 
Unconsolidated Variable Interest Entities
 
 
 
 
 
LEAF
Commercial
Capital, Inc.
 
Unsecured
Junior
Subordinated
Debentures
 
Resource
Capital
Asset
Management
CLOs
 
RRE VIP
Borrower,
LLC
 
Värde
Investment
Partners,
LP
 
Total
 
Maximum
Exposure
to Loss (1)
Investment in
unconsolidated entities
$
32,736

 
$
1,548

 
$

 
$
1,686

 
$
550

 
$
36,520

 
$
36,520

Intangible assets

 

 
12,589

 

 

 
12,589

 
$
12,589

Total assets
32,736

 
1,548

 
12,589

 
1,686

 
550

 
49,109

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Borrowings

 
50,861

 

 

 

 
50,861

 
N/A

Total liabilities

 
50,861

 

 

 

 
50,861

 
N/A

Net asset (liability)
$
32,736

 
$
(49,313
)
 
$
12,589

 
$
1,686

 
$
550

 
$
(1,752
)
 
N/A

 
(1)
RSO's maximum exposure to loss at March 31, 2013 does not exceed the carrying amount of its investment.
Schedule of Other Significant Noncash Transactions
Supplemental disclosure of cash flow information (in thousands):
 
Three Months Ended
 
March 31,
 
2013
 
2012
Non-cash financing activities include the following:
 

 
 

Distributions on common stock declared but not paid
$
21,634

 
$
17,000

Distribution on preferred stock declared but not paid
$
1,311

 
$

Income taxes paid in cash
$
7,635

 
$
10,103

Issuance of restricted stock
$
35

 
$
472

Investment trading securities at fair value
The following table summarizes RSO's structured notes and residential mortgage-backed securities (“RMBS”) which are classified as investment securities, trading and carried at fair value (in thousands):
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
March 31, 2013:
 
 
 
 
 
 
 
Structured notes
$
16,803

 
$
10,964

 
$
(1,005
)
 
$
26,762

RMBS
6,025

 
1,426

 
(1,321
)
 
6,130

Total
$
22,828

 
$
12,390

 
$
(2,326
)
 
$
32,892

 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

 
 

Structured notes
$
9,413

 
$
10,894

 
$
(1,028
)
 
$
19,279

RMBS
6,047

 
858

 
(1,341
)
 
5,564

Total
$
15,460

 
$
11,752

 
$
(2,369
)
 
$
24,843

Available-for-sale securities, fair value
The following table summarizes RSO's investment securities, including those pledged as collateral and classified as available-for-sale, which are carried at fair value (in thousands):
 
Amortized
Cost
(1) 
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
March 31, 2013
 
 
 
 
 
 
 
CMBS
$
189,990

 
$
7,766

 
$
(16,201
)
 
$
181,555

ABS
23,682

 
1,851

 
(712
)
 
24,821

Corporate bonds
35,678

 
256

 
(51
)
 
35,883

Other asset-backed

 
23

 

 
23

Total
$
249,350

 
$
9,896

 
$
(16,964
)
 
$
242,282

 
 
 
 
 
 
 
 
December 31, 2012
 

 
 

 
 

 
 

CMBS
$
182,828

 
$
4,626

 
$
(16,639
)
 
$
170,815

ABS
26,479

 
1,700

 
(1,115
)
 
27,064

Corporate Bonds
33,767

 
111

 
(190
)
 
33,688

Other asset-backed

 
23

 

 
23

Total
$
243,074

 
$
6,460

 
$
(17,944
)
 
$
231,590

 
(1)
As of March 31, 2013 and December 31, 2012, $192.7 million and $195.2 million, respectively, of securities were pledged as collateral security under related financings.
Estimated maturities of available-for-sale securities
The following table summarizes the estimated maturities of RSO’s CMBS, ABS, and corporate bonds according to their estimated weighted average life classifications (in thousands, except percentages):
Weighted Average Life
Fair Value
 
Amortized
Cost
 
Weighted
Average
Coupon
March 31, 2013
 
 
 
 
 
Less than one year
$
46,592

(1) 
$
50,319

 
4.30%
Greater than one year and less than five years
131,401

 
135,955

 
4.51%
Greater than five years and less than ten years
54,758

 
53,475

 
3.42%
Greater than ten years
9,531

 
9,601

 
3.70%
Total
$
242,282

 
$
249,350

 
4.19%
 
 
 
 
 
 
December 31, 2012
 

 
 

 
 
Less than one year
$
42,618

(1) 
$
46,522

 
4.09%
Greater than one year and less than five years
122,509

 
131,076

 
4.55%
Greater than five years and less than ten years
61,780

 
60,801

 
3.31%
Greater than ten years
4,683

 
4,675

 
4.03%
Total
$
231,590

 
$
243,074

 
4.12%
 
(1)    RSO expects that the maturity date of these CMBS will either be extended or the CMBS will be paid in full.
Gross unrealized loss and fair value of securities
The following table shows the fair value and gross unrealized losses, aggregated by investment category and length of time, of those individual investment securities available-for-sale that have been in a continuous unrealized loss position during the periods specified (in thousands):
 
Less than 12 Months
 
More than 12 Months
 
Total
 
Fair Value
 
Gross
Unrealized
Losses
 
Fair Value
 
Gross
Unrealized
Losses
 
Fair Value
 
Gross
Unrealized
Losses
March 31, 2013
 
 
 
 
 
 
 
 
 
 
 
CMBS
$
42,706

 
$
(893
)
 
$
21,498

 
$
(15,308
)
 
$
64,204

 
$
(16,201
)
ABS

 

 
6,365

 
(712
)
 
6,365

 
(712
)
Corporate bonds
14,203

 
(51
)
 

 

 
14,203

 
(51
)
Total temporarily impaired securities
$
56,909

 
$
(944
)
 
$
27,863

 
$
(16,020
)
 
$
84,772

 
$
(16,964
)
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012
 

 
 

 
 

 
 

 
 

 
 

CMBS
$
25,803

 
$
(442
)
 
$
38,734

 
$
(16,197
)
 
$
64,537

 
$
(16,639
)
ABS

 

 
5,961

 
(1,115
)
 
5,961

 
(1,115
)
Corporate bonds
19,445

 
(190
)
 

 

 
19,445

 
(190
)
Total temporarily impaired securities
$
45,248

 
$
(632
)
 
$
44,695

 
$
(17,312
)
 
$
89,943

 
$
(17,944
)
Investments in real estate
The table below summarizes RSO’s investments in real estate (in thousands):
 
As of March 31, 2013
 
As of December 31, 2012
 
Book Value
 
Number of
Properties
 
Book Value
 
Number of
Properties
Multi-family property
$
42,538

 
2
 
$
42,179

 
2
Office property
10,149

 
1
 
10,149

 
1
Hotel property
25,668

 
1
 
25,608

 
1
Subtotal
78,355

 
 
 
77,936

 
 
Less:  Accumulated depreciation
(3,213
)
 
 
 
(2,550
)
 
 
Investments in real estate
$
75,142

 
 
 
$
75,386

 
 
Aggregate estimated fair value of assets and liabilities acquired
The following table is a summary of the aggregate estimated fair value of the assets and liabilities acquired on the respective date of acquisition during the year ended December 31, 2012 (in thousands). There were no such acquisitions during the three months ended March 31, 2013.
Description
 
December 31, 2012
Assets acquired:
 
 
Investments in real estate
 
$
25,500

Other assets
 
(89
)
Total assets acquired
 
25,411

Liabilities assumed:
 
 

Accounts payable and other liabilities
 
3,750

Total liabilities assumed
 
3,750

Estimated fair value of net assets acquired
 
$
21,661

Summary of loans held for Investments
The following is a summary of RSO’s loans (in thousands):
Loan Description
 
Principal
 
Unamortized
(Discount)
Premium (1)
 
Carrying
Value (2)
March 31, 2013
 
 
 
 
 
 
Bank loans (3) 
 
$
1,114,684

 
$
(20,501
)
 
$
1,094,183

Commercial real estate loans:
 
 

 
 

 
 

Whole loans
 
552,449

 
(2,035
)
 
550,414

B notes
 
16,399

 
(106
)
 
16,293

Mezzanine loans
 
82,967

 
(191
)
 
82,776

Total commercial real estate loans
 
651,815

 
(2,332
)
 
649,483

Subtotal loans before allowances
 
1,766,499

 
(22,833
)
 
1,743,666

Allowance for loan loss
 
(16,976
)
 

 
(16,976
)
Total
 
$
1,749,523

 
$
(22,833
)
 
$
1,726,690

 
 
 
 
 
 
 
December 31, 2012
 
 

 
 

 
 

Bank loans (3) 
 
$
1,218,563

 
$
(25,249
)
 
$
1,193,314

Commercial real estate loans:
 
 

 
 

 
 

Whole loans (4)
 
569,829

 
(1,891
)
 
567,938

B notes
 
16,441

 
(114
)
 
16,327

Mezzanine loans
 
82,992

 
(206
)
 
82,786

Total commercial real estate loans
 
669,262

 
(2,211
)
 
667,051

Subtotal loans before allowances
 
1,887,825

 
(27,460
)
 
1,860,365

Allowance for loan loss
 
(17,691
)
 

 
(17,691
)
Total
 
$
1,870,134

 
$
(27,460
)
 
$
1,842,674

 
(1)
Amounts include deferred amendment fees of $375,000 and $450,000 and deferred upfront fees of $310,000 and $334,000 being amortized over the life of the bank loans as of March 31, 2013 and December 31, 2012, respectively.  Amounts include loan origination fees of $2.0 million and $1.9 million and loan extension fees of $194,000 and $214,000 being amortized over the life of the commercial real estate loans as of March 31, 2013 and December 31, 2012, respectively.
(2)
Substantially all loans are pledged as collateral under various borrowings at March 31, 2013 and December 31, 2012, respectively.
(3)
Amounts include $18.2 million and $14.9 million of bank loans held for sale at March 31, 2013 and December 31, 2012, respectively.
(4)
Amount includes $34.0 million from two whole loans which are classified as loans held for sale at December 31, 2012.
Summary of the weighted average life of bank loans at amortized cost
The following is a summary of the weighted average life of RSO’s bank loans, at amortized cost (in thousands):
 
March 31,
2013
 
December 31,
2012
Less than one year
$
31,046

 
$
10,028

Greater than one year and less than five years
687,786

 
821,568

Five years or greater
375,351

 
361,718

 
$
1,094,183

 
$
1,193,314

    
Summary of the commercial real estate loans
The following is a summary of RSO’s commercial real estate loans held for investment (dollars in thousands):
Description
 
Quantity
 
Amortized Cost
 
Contracted
Interest Rates
 
Maturity
Dates (3)
March 31, 2013:
 
 
 
 
 
 
 
 
Whole loans, floating rate (1) (5)
 
35
 
$
550,414

 
LIBOR plus 2.50% to
LIBOR plus 5.5%
 
June 2013 to
February 2019
B notes, fixed rate
 
1
 
16,293

 
8.68%
 
April 2016
Mezzanine loans, floating rate
 
2
 
15,848

 
LIBOR plus 2.50% to
LIBOR plus 7.45%
 
August 2013 to
December 2013
Mezzanine loans, fixed rate (7)
 
3
 
66,928

 
0.50% to 20.00%
 
September 2014 to
September 2019
Total (2) 
 
41
 
$
649,483

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012:
 
 
 
 

 
 
 
 
Whole loans, floating rate (1) (4) (5) (6)
 
37
 
$
567,938

 
LIBOR plus 2.50% to
LIBOR plus 5.50%
 
June 2013 to
February 2019
B notes, fixed rate
 
1
 
16,327

 
8.68%
 
April 2016
Mezzanine loans, floating rate
 
2
 
15,845

 
LIBOR plus 2.50% to
LIBOR plus 7.45%
 
August 2013 to
December 2013
Mezzanine loans, fixed rate (7)
 
3
 
66,941

 
0.50% to 20.00%
 
September 2014 to
September 2019
Total (2) 
 
43
 
$
667,051

 
 
 
 
 
(1)
Whole loans had $9.5 million and $8.9 million in unfunded loan commitments as of March 31, 2013 and December 31, 2012, respectively.  These commitments are funded as the borrowers request additional funding and have satisfied the requirements to obtain this additional funding.
(2)
The total does not include an allowance for loan loss of $9.2 million and $8.0 million as of March 31, 2013 and December 31, 2012, respectively.
(3)
Maturity dates do not include possible extension options that may be available to the borrowers.
(4)
Floating rate whole loans include a $2.0 million portion of a whole loan that has a fixed rate of 15% as of December 31, 2012.
(5)
Floating rate whole loans include a $1.0 million portion of a whole loan that has a fixed rate of 10% as of March 31, 2013 and December 31, 2012, respectively.
(6)
Amount includes $34.0 million from two whole loans that were classified as loans held for sale at December 31, 2012.
(7)
Fixed rate mezzanine loans include a mezzanine loan that was modified into two tranches which both currently pay interest at 0.50%. In addition, the subordinate tranche accrues interest at LIBOR plus 18.5% which is deferred until maturity.
Summary of the weighted average life of the commercial real estate loans at amortized cost
The following is a summary of the weighted average life of RSO’s commercial real estate loans, at amortized cost (in thousands):
Description
 
2013
 
2014
 
2015 and Thereafter
 
Total
March 31, 2013
 
 
 
 
 
 
 
 
B notes
 
$

 
$

 
$
16,293

 
$
16,293

Mezzanine loans
 
5,331

 
20,710

 
56,735

 
82,776

Whole loans
 
3,312

 

 
547,102

 
550,414

Total (1) 
 
$
8,643

 
$
20,710

 
$
620,130

 
$
649,483

 
 
 
 
 
 
 
 
 
December 31, 2012
 
 
 
 
 
 
 
 
B notes
 
$

 
$

 
$
16,327

 
$
16,327

Mezzanine loans
 
5,328

 
20,694

 
56,764

 
82,786

Whole loans
 
71,799

 

 
496,139

 
567,938

Total (1) 
 
$
77,127

 
$
20,694

 
$
569,230

 
$
667,051

 
(1)
Weighted average life of commercial real estate loans assumes full exercise of extension options available to borrowers.
Allocation of allowance for loan loss
The following is a summary of the allocation of the allowance for loan loss with respect to RSO’s commercial real estate and bank loans (in thousands, except percentages) by asset class:
Description
 
Allowance for
Loan Loss
 
Percentage of
Total Allowance
March 31, 2013:
 
 
 
 
B notes
 
$
219

 
1.29%
Mezzanine loans
 
914

 
5.38%
Whole loans
 
8,022

 
47.26%
Bank loans
 
7,821

 
46.07%
Total
 
$
16,976

 
 
 
 
 
 
 
December 31, 2012:
 
 

 
 
B notes
 
$
206

 
1.17%
Mezzanine loans
 
860

 
4.85%
Whole loans
 
6,920

 
39.12%
Bank loans
 
9,705

 
54.86%
Total
 
$
17,691

 
 
Allowance for loan losses and recorded investments
The following tables show the allowance for loan losses and recorded investments in loans for the years indicated (in thousands):
 
Commercial Real Estate Loans
 
Bank Loans
 
Loans Receivable-Related Party
 
Total
March 31, 2013:
 
 
 
 
 
 
 
Allowance for Loan Losses:
 
 
 
 
 
 
 
Allowance for losses at January 1, 2013
$
7,986

 
$
9,705

 
$

 
$
17,691

Provision (benefit) for loan loss
1,261

 
(219
)
 

 
1,042

Loans charged-off
(92
)
 
(1,665
)
 

 
(1,757
)
Allowance for losses at March 31, 2013
$
9,155

 
$
7,821

 
$

 
$
16,976

Ending balance:
 

 
 

 
 

 
 

Individually evaluated for impairment
$
3,311

 
$
2,607

 
$

 
$
5,918

Collectively evaluated for impairment
$
5,844

 
$
5,214

 
$

 
$
11,058

Loans acquired with deteriorated credit quality
$

 
$

 
$

 
$

Loans:
 

 
 

 
 

 
 

Ending balance:
 

 
 

 
 

 
 

Individually evaluated for impairment
$
180,262

 
$
3,896

 
$
7,860

 
$
192,018

Collectively evaluated for impairment
$
469,221

 
$
1,090,287

 
$

 
$
1,559,508

Loans acquired with deteriorated credit quality
$

 
$

 
$

 
$

 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

 
 

Allowance for Loan Losses:
 
 
 
 
 
 
 
Allowance for losses at January 1, 2012
$
24,221

 
$
3,297

 
$

 
$
27,518

Provision for loan loss
5,225

 
11,593

 

 
16,818

Loans charged-off
(21,460
)
 
(5,185
)
 

 
(26,645
)
Allowance for losses at December 31, 2012
$
7,986

 
$
9,705

 
$

 
$
17,691

Ending balance:
 

 
 

 
 

 
 

Individually evaluated for impairment
$
2,142

 
$
3,236

 
$

 
$
5,378

Collectively evaluated for impairment
$
5,844

 
$
6,469

 
$

 
$
12,313

Loans acquired with deteriorated credit quality
$

 
$

 
$

 
$

Loans:
 

 
 

 
 

 
 

Ending balance:
 

 
 

 
 

 
 

Individually evaluated for impairment
$
177,055

 
$
4,689

 
$
8,324

 
$
190,068

Collectively evaluated for impairment
$
489,996

 
$
1,187,874

 
$

 
$
1,677,870

Loans acquired with deteriorated credit quality
$

 
$
751

 
$

 
$
751

Credit quality indicators for Bank loans and Commercial real estate loans
Credit risk profiles of bank loans were as follows (in thousands):
 
Rating 1
 
Rating 2
 
Rating 3
 
Rating 4
 
Rating 5
 
Held for Sale
 
Total
As of March 31, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
Bank loans
$
979,854

 
$
43,387

 
$
32,626

 
$
16,270

 
$
3,896

 
$
18,150

 
$
1,094,183

 
 
 
 
 
 
 
 
 
 
 
 
 
 
As of December 31, 2012
 

 
 

 
 

 
 

 
 

 
 

 
 
Bank loans
$
1,095,148

 
$
33,677

 
$
27,837

 
$
16,318

 
$
5,440

 
$
14,894

 
$
1,193,314

Credit risk profiles of commercial real estate loans were as follows (in thousands):
 
Rating 1
 
Rating 2
 
Rating 3
 
Rating 4
 
Held for Sale
 
Total
As of March 31, 2013
 
 
 
 
 
 
 
 
 
 
 
Whole loans
$
497,052

 
$

 
$
53,362

 
$

 
$

 
$
550,414

B notes
16,293

 

 

 

 

 
16,293

Mezzanine loans
44,704

 

 
38,072

 

 

 
82,776

 
$
558,049

 
$

 
$
91,434

 
$

 
$

 
$
649,483

 
 
 
 
 
 
 
 
 
 
 
 
As of December 31, 2012
 

 
 

 
 

 
 

 
 

 
 

Whole loans
$
427,456

 
$

 
$
106,482

 
$

 
$
34,000

 
$
567,938

B notes
16,327

 

 

 

 

 
16,327

Mezzanine loans
38,296

 

 
44,490

 

 

 
82,786

 
$
482,079

 
$

 
$
150,972

 
$

 
$
34,000

 
$
667,051

Loan portfolios aging analysis
The following table shows the loan portfolio aging analysis as of the dates indicated at cost basis (in thousands):
 
30-59 Days
 
60-89 Days
 
Greater than 90 Days
 
Total Past Due
 
Current
 
Total Loans Receivable
 
Total Loans > 90 Days and Accruing
March 31, 2013:
 

 
 

 
 
 
 
 
 
 
 
 
 
Whole loans
$

 
$

 
$

 
$

 
$
550,414

 
$
550,414

 
$

B notes

 

 

 

 
16,293

 
16,293

 

Mezzanine loans

 

 

 

 
82,776

 
82,776

 

Bank loans

 
1,553

 
2,343

 
3,896

 
1,090,287

 
1,094,183

 

Loans receivable- related party

 

 

 

 
7,860

 
7,860

 

Total loans
$

 
$
1,553

 
$
2,343

 
$
3,896

 
$
1,747,630

 
$
1,751,526

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

 
 

 
 

 
 

 
 

Whole loans
$

 
$

 
$

 
$

 
$
567,938

 
$
567,938

 
$

B notes

 

 

 

 
16,327

 
16,327

 

Mezzanine loans

 

 

 

 
82,786

 
82,786

 

Bank loans
1,549

 

 
3,891

 
5,440

 
1,187,874

 
1,193,314

 

Loans receivable- related party

 

 

 

 
8,324

 
8,324

 

Total loans
$
1,549

 
$

 
$
3,891

 
$
5,440

 
$
1,863,249

 
$
1,868,689

 
$

Impaired loans
The following tables show impaired loans in the categories indicated (in thousands):
 
Recorded Balance
 
Unpaid Principal Balance
 
Specific Allowance
 
Average Investment in Impaired Loans
 
Interest Income Recognized
March 31, 2013:
 
 
 
 
 
 
 
 
 
Loans without a specific valuation allowance:
 
 
 
 
 
 
 
 
 
Whole loans
$
116,628

 
$
116,628

 
$

 
$
115,037

 
$
4,515

B notes

 

 

 

 

Mezzanine loans
38,072

 
38,072

 

 
38,072

 
675

Bank loans

 

 

 

 

Loans receivable - related party
6,289

 
6,289

 

 

 
178

Loans with a specific valuation allowance:
 

 
 

 
 

 
 

 
 

Whole loans
24,313

 
24,313

 
(3,313
)
 
22,872

 
995

B notes

 

 

 

 

Mezzanine loans

 

 

 

 

Bank loans
3,896

 
3,896

 
(2,607
)
 

 

Loans receivable - related party

 

 

 

 

 
 
 
 
 
 
 
 
 
 
Total:
 

 
 

 
 

 
 

 
 

Whole loans
$
140,941

 
$
140,941

 
$
(3,313
)
 
$
137,909

 
$
5,510

B notes

 

 

 

 

Mezzanine loans
38,072

 
38,072

 

 
38,072

 
675

Bank loans
3,896

 
3,896

 
(2,607
)
 

 

Loans receivable - related party
6,289

 
6,289

 

 

 
178

 
$
189,198

 
$
189,198

 
$
(5,920
)
 
$
175,981

 
$
6,363

 
 
 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

 
 

 
 

Loans without a specific valuation allowance:
 

 
 

 
 

 
 

 
 

Whole loans
$
115,841

 
$
115,841

 
$

 
$
114,682

 
$
3,436

B notes

 

 

 

 

Mezzanine loans
38,072

 
38,072

 

 
38,072

 
367

Bank loans

 

 

 

 

Loans receivable - related party
6,754

 
6,754

 

 

 
851

Loans with a specific valuation allowance:
 

 
 

 
 

 
 

 
 

Whole loans
23,142

 
23,142

 
(2,142
)
 
22,576

 
801

B notes

 

 

 

 

Mezzanine loans

 

 

 

 

Bank loans
5,440

 
5,440

 
(3,236
)
 

 

Loans receivable - related party

 

 

 

 

 
 
 
 
 
 
 
 
 
 
Total:
 

 
 

 
 

 
 

 
 

Whole loans
$
138,983

 
$
138,983

 
$
(2,142
)
 
$
137,258

 
$
4,237

B notes

 

 

 

 

Mezzanine loans
38,072

 
38,072

 

 
38,072

 
367

Bank loans
5,440

 
5,440

 
(3,236
)
 

 

Loans receivable - related party
6,754

 
6,754

 

 

 
851

 
$
189,249

 
$
189,249

 
$
(5,378
)
 
$
175,330

 
$
5,455

Troubled debt restructurings on financing receivables
The following tables show troubled-debt restructurings in RSO's loan portfolio (in thousands):
 
Number of Loans
 
Pre-Modification Outstanding Recorded Balance
 
Post-Modification Outstanding Recorded Balance
Three Months Ended March 31, 2013:
 
 
 
 
 
Whole loans
6
 
$
153,958

 
$
136,672

B notes
 

 

Mezzanine loans
1
 
38,072

 
38,072

Bank loans
 

 

Loans receivable - related party
1
 
7,797

 
7,797

Total loans
8
 
$
199,827

 
$
182,541

 
 
 
 
 
 
Three Months Ended March 31, 2012:
 
 
 

 
 

Whole loans
4
 
$
133,955

 
$
115,894

B notes
 

 

Mezzanine loans
 

 

Bank loans
 

 

Loans receivable
 

 

Loans receivable - related party
1
 
7,797

 
7,797

Total loans
5
 
$
141,752

 
$
123,691

Summary of intangible assets
The following table summarizes intangible assets at March 31, 2013 and December 31, 2012 (in thousands).
 
Beginning Balance
 
Accumulated Amortization
 
Net Assets
March 31, 2013:
 
 
 
 
 
Investment in RCAM
$
21,213

 
$
(8,624
)
 
$
12,589

Investments in real estate:
 

 
 

 
 

In-place leases
2,461

 
(2,394
)
 
67

Above (below) market leases
29

 
(25
)
 
4

 
2,490

 
(2,419
)
 
71

Total intangible assets
$
23,703

 
$
(11,043
)
 
$
12,660

 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

Investment in RCAM
$
21,213

 
$
(8,108
)
 
$
13,105

Investments in real estate:
 

 
 

 
 

In-place leases
2,461

 
(2,379
)
 
82

Above (below) market leases
29

 
(24
)
 
5

 
2,490

 
(2,403
)
 
87

Total intangible assets
$
23,703

 
$
(10,511
)
 
$
13,192

Schedule of Debt
Certain information with respect to RSO’s borrowings at March 31, 2013 and December 31, 2012 is summarized in the following table (in thousands, except percentages):
 
Outstanding
Borrowings
 
Weighted
Average
Borrowing
Rate
 
Weighted
Average
Remaining
Maturity
 
Value of
Collateral
March 31, 2013:
 
 
 
 
 
 
 
RREF CDO 2006-1 Senior Notes (1) 
$
116,220

 
1.64%
 
33.4 years
 
$
200,401

RREF CDO 2007-1 Senior Notes (2) 
199,233

 
0.83%
 
33.5 years
 
344,963

Apidos CDO I Senior Notes (3) 
174,493

 
1.14%
 
4.3 years
 
189,304

Apidos CDO III Senior Notes (4) 
193,248

 
0.80%
 
7.2 years
 
204,281

Apidos Cinco CDO Senior Notes (5) 
320,699

 
0.80%
 
7.1 years
 
345,983

Apidos CLO VIII Senior Notes (6) 
301,606

 
2.13%
 
8.6 years
 
353,860

Apidos CLO VIII Securitized Borrowings (11)
19,576

 
15.27%
 
8.6 years
 

Whitney CLO I Senior Notes(10)
144,190

 
1.85%
 
3.9 years
 
164,267

     Whitney CLO I Securitized Borrowings (11)
5,749

 
9.09%
 
3.9 years
 

Unsecured Junior Subordinated Debentures (7)
50,861

 
4.24%
 
23.4 years
 

Repurchase Agreements (8)
110,365

 
2.19%
 
18 days
 
148,545

Mortgage Payable (9)
13,600

 
4.15%
 
5.3 years
 
18,100

Total
$
1,649,840

 
1.66%
 
11.9 years
 
$
1,969,704

 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 
 
 
 
 

RREF CDO 2006-1 Senior Notes (1) 
$
145,664

 
1.42%
 
33.6 years
 
$
295,759

RREF CDO 2007-1 Senior Notes (2) 
225,983

 
0.81%
 
33.8 years
 
292,980

Apidos CDO I Senior Notes (3) 
202,969

 
1.07%
 
4.6 years
 
217,745

Apidos CDO III Senior Notes (4) 
221,304

 
0.80%
 
7.5 years
 
232,655

Apidos Cinco CDO Senior Notes (5) 
320,550

 
0.82%
 
7.4 years
 
344,105

Apidos CLO VIII Senior Notes (6) 
300,951

 
2.16%
 
8.8 years
 
351,014

Apidos CLO VIII Securitized Borrowings (11)
20,047

 
15.27%
 
8.8 years
 

Whitney CLO I Senior Notes(10)
171,555

 
1.82%
 
4.2 years
 
191,704

Whitney CLO I Securitized Borrowings (11)
5,860

 
9.50%
 
4.2 years
 

Unsecured Junior Subordinated Debentures (7)
50,814

 
4.26%
 
23.7 years
 

Repurchase Agreements (8)
106,303

 
2.28%
 
18 days
 
145,234

Mortgage Payable (9)
13,600

 
4.17%
 
5.6 years
 
18,100

Total
$
1,785,600

 
1.62%
 
12.5 years
 
$
2,089,296

 
(1)
Amount represents principal outstanding of $116.7 million and $146.4 million less unamortized issuance costs of $499,000 and $728,000 as of March 31, 2013 and December 31, 2012, respectively.  This CDO transaction closed in August 2006.
(2)
Amount represents principal outstanding of $200.4 million and $227.4 million less unamortized issuance costs of $1.1 million and $1.4 million as of March 31, 2013 and December 31, 2012, respectively.  This CDO transaction closed in June 2007.
(3)
Amount represents principal outstanding of $174.6 million and $203.2 million less unamortized issuance costs of $148,000 and $274,000 as of March 31, 2013 and December 31, 2012, respectively.  This CDO transaction closed in August 2005.
(4)
Amount represents principal outstanding of $193.7 million and $222.0 million less unamortized issuance costs of $474,000 and $659,000 as of March 31, 2013 and December 31, 2012, respectively.  This CDO transaction closed in May 2006.
(5)
Amount represents principal outstanding of $322.0 million and $322.0 million less unamortized issuance costs of $1.3 million and $1.5 million as of March 31, 2013 and December 31, 2012, respectively.  This CDO transaction closed in May 2007.
(6)
Amount represents principal outstanding of $317.6 million and $317.6 million, less unamortized issuance costs of $4.5 million and $4.7 million, and less unamortized discounts of $11.5 million and $11.9 million as of March 31, 2013 and December 31, 2012, respectively.  This CDO transaction closed in October 2011. Apidos CLO VIII was called and the notes were paid in full in October 2013.
(7)
Amount represents junior subordinated debentures issued to RCT I and RCT II in May 2006 and September 2006, respectively.
(8)
Amount represents principal outstanding of $44.1 million and $47.5 million less unamortized deferred debt costs of $117,000 and $23,000 plus accrued interest costs of $24,000 and $37,000 related to CMBS repurchase facilities as of March 31, 2013 and December 31, 2012, respectively, and principal outstanding of $64.4 million and $59.1 million less unamortized deferred debt costs of $219,000 and $348,000 plus accrued interest costs of $87,000 and $79,000 related to CRE repurchase facilities as of March 31, 2013 and December 31, 2012. Amount does not reflect CMBS repurchase agreement borrowings that are components of Linked Transactions. At March 31, 2013 and December 31, 2012, RSO had repurchase agreements of $53.6 million and $20.4 million, respectively, that were linked to CMBS purchases and accounted for as Linked Transactions, and, as such, the linked repurchase agreements are not included in the above table.
(9)
Amount represents principal outstanding of $13.6 million as of March 31, 2013 and December 31, 2012, respectively. This real estate transaction closed in August 2011.
(10)
Amount represents principal outstanding of $146.3 million less unamortized discounts of $2.1 million as of December 31, 2012. In September 2013, the Company called and liquidated Whitney CLO I. As a result, substantially all of the remaining assets were sold and the balance on the outstanding notes totaling $20.9 million was paid down.
(11)
The securitized borrowings are collateralized by the same assets as the Apidos CLO VIII Senior Notes and the Whitney CLO I Senior Notes, respectively.
Fair value assets and liabilities measured on recurring basis
The following table presents information about RSO’s assets (including derivatives that are presented net) measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques utilized by RSO to determine such fair value as follows (in thousands):
   
Level 1
 
Level 2
 
Level 3
 
Total
March 31, 2013:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Investment securities, trading
$

 
$

 
$
32,892

 
$
32,892

Investment securities available-for-sale
11,397

 
113,378

 
117,507

 
242,282

CMBS - linked transactions

 
10,808

 
11,647

 
22,455

Total assets at fair value
$
11,397

 
$
124,186

 
$
162,046

 
$
297,629

 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

Derivatives (net)
$

 
$
558

 
$
13,478

 
$
14,036

Total liabilities at fair value
$

 
$
558

 
$
13,478

 
$
14,036

 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

 
 

Assets:
 

 
 

 
 

 
 

Investment securities, trading
$

 
$

 
$
24,843

 
$
24,843

Investment securities available-for-sale
9,757

 
132,561

 
89,272

 
231,590

CMBS - linked transactions

 
4,802

 
2,033

 
6,835

Total assets at fair value
$
9,757

 
$
137,363

 
$
116,148

 
$
263,268

 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

Derivatives (net)
$

 
$
610

 
$
14,077

 
$
14,687

Total liabilities at fair value
$

 
$
610

 
$
14,077

 
$
14,687

Fair value assets unobservable input reconciliation
The following table presents additional information about assets which are measured at fair value on a recurring basis for which RSO has utilized Level 3 inputs (in thousands):
 
Level 3
Beginning balance, January 1, 2013
$
116,148

Total gains or losses (realized/unrealized):
 

Included in earnings
1,564

Purchases
46,980

Sales
(3,249
)
Paydowns
(1,632
)
Unrealized gains (losses) – included in accumulated other comprehensive income
2,235

Transfers from level 2

Ending balance, March 31, 2013
$
162,046

Fair value liabilities unobservable input reconciliation
The following table presents additional information about liabilities which are measured at fair value on a recurring basis for which RSO has utilized Level 3 inputs (in thousands):
 
Level 3
Beginning balance, January 1, 2013                                                                                            
$
14,077

Unrealized gains – included in accumulated other comprehensive income
(599
)
Ending balance, March 31, 2013                                                                                            
$
13,478

Fair value assets and liabilities measured on nonrecurring basis
The following table summarizes the financial assets and liabilities measured at fair value on a nonrecurring basis and indicates the fair value hierarchy of the valuation techniques utilized by RSO to determine such fair value as follows (in thousands):
 
Level 1
 
Level 2
 
Level 3
 
Total
March 31, 2013:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Loans held for sale
$

 
$
18,150

 
$

 
$
18,150

Total assets at fair value
$

 
$
18,150

 
$

 
$
18,150

 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

 
 

Assets:
 

 
 

 
 

 
 

Loans held for sale
$

 
$
14,894

 
$
34,000

 
$
48,894

Impaired loans

 
4,366

 
21,000

 
25,366

Total assets at fair value
$

 
$
19,260

 
$
55,000

 
$
74,260

Significant unobservable inputs used in fair value measurements
For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of March 31, 2013, the significant unobservable inputs used in the fair value measurements were as follows (in thousands):
 
Fair Value at
March 31, 2013
 
Valuation Technique
 
Significant Unobservable Inputs
 
Significant
Unobservable
Input Value
Interest rate swap agreements
$
(14,036
)
 
Discounted cash flow
 
Weighted average credit spreads
 
5.01%
Fair value financial instruments not reported at fair value
The fair values of RSO’s remaining financial instruments that are not reported at fair value on the RSO consolidated balance sheets are reported below (in thousands):
 
 
 
Fair Value Measurements
 
Carrying Amount
 
Fair Value
 
Quoted Prices
in Active Markets
for Identical
Assets of Liabilities
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
March 31, 2013:
 
 
 
 
 
 
 
 
 
Loans held-for-investment
$
1,708,540

 
$
1,728,878

 
$

 
$
1,086,102

 
$
642,776

Loans receivable-related party
$
7,860

 
$
7,860

 
$

 
$

 
$
7,860

CDO notes
$
1,475,014

 
$
1,295,372

 
$

 
$
1,295,372

 
$

Junior subordinated notes
$
50,861

 
$
17,355

 
$

 
$

 
$
17,355

Repurchase agreement
$
110,365

 
$
110,365

 
$

 
$

 
$
110,365

 
 
 
 
 
 
 
 
 
 
December 31, 2012:
 

 
 

 
 

 
 

 
 

Loans held-for-investment
$
1,793,780

 
$
1,848,617

 
$

 
$
1,186,642

 
$
661,975

Loans receivable-related party
$
8,324

 
$
8,324

 
$

 
$

 
$
8,324

CDO notes
$
1,614,883

 
$
1,405,124

 
$

 
$
1,405,124

 
$

Junior subordinated notes
$
50,814

 
$
17,308

 
$

 
$

 
$
17,308

Repurchase agreement
$
106,303

 
$
106,303

 
$

 
$

 
$
106,303

Resource Capital Corp [Member] | CMBS - Term Repurchase Facilities [Member]
 
Debt Instrument [Line Items]  
Schedule of Amount at Risk under Credit Facility
The following table shows information about the amount at risk under this facility (dollars in thousands):
 
Amount at
Risk (1)
 
Weighted
Average
Maturity in Days
 
Weighted
Average
Interest Rate
March 31, 2013:
 
 
 
 
 
Wells Fargo Bank, National Association (2)
$
10,345

 
18
 
1.48
%
 
 
 
 
 
 
December 31, 2012:
 

 
 
 
 

Wells Fargo Bank, National Association (2)
$
10,722

 
18
 
1.53
%
 
(1)
Equal to the estimated fair value of securities or loans sold, plus accrued interest income, minus the sum of repurchase agreement liabilities plus accrued interest expense.
(2)
$13.3 million and $12.2 million of linked repurchase agreement borrowings are being included as derivative instruments as of March 31, 2013 and December 31, 2012, respectively.
Resource Capital Corp [Member] | CRE - Term Repurchase Facility [Member]
 
Debt Instrument [Line Items]  
Schedule of Amount at Risk under Credit Facility
The following table shows information about the amount at risk under the facility (dollars in thousands);
 
Amount at
Risk (1)
 
Weighted
Average
Maturity in Days
 
Weighted
Average
Interest Rate
March 31, 2013:
 
 
 
 
 
Wells Fargo Bank, National Association
$
28,831

 
18
 
2.70
%
 
 
 
 
 
 
December 31, 2012:
 

 
 
 
 

Wells Fargo Bank, National Association
$
26,332

 
18
 
2.88
%
 
(1)
Equal to the estimated fair value of securities or loans sold, plus accrued interest income, minus the sum of repurchase agreement liabilities plus accrued interest expense.
Resource Capital Corp [Member] | Repurchase Agreements [Member] | JP Morgan Securities, LLC [Member]
 
Debt Instrument [Line Items]  
Schedule of Amount at Risk under Credit Facility
The following table shows information about the amount at risk under this facility (dollars in thousands):
 
Amount at
Risk (1)
 
Weighted
Average
Maturity in Days
 
Weighted
Average
Interest Rate
March 31, 2013
 
 
 
 
 
JP Morgan Securities, LLC (2)
$
6,965

 
12
 
1.07
%
 
 
 
 
 
 
December 31, 2012:
 
 
 
 
 
JP Morgan Securities, LLC (2)
$
2,544

 
11
 
1.01
%
 
(1)
Equal to the estimated fair value of securities or loans sold, plus accrued interest income, minus the sum of repurchase agreement liabilities plus accrued interest expense.
(2)
$13.5 million and $4.7 million linked repurchase agreement borrowings are being included as derivative instruments as of March 31, 2013 and December 31, 2012.
Resource Capital Corp [Member] | Repurchase Agreements [Member] | Wells Fargo Securities, LLC [Member]
 
Debt Instrument [Line Items]  
Schedule of Amount at Risk under Credit Facility
The following table shows information about the amount at risk under this facility (dollars in thousands);
 
Amount at
Risk (1)
 
Weighted
Average
Maturity in Days
 
Weighted
Average
Interest Rate
March 31, 2013
 
 
 
 
 
Wells Fargo Securities, LLC (2)
$
8,837

 
1
 
1.25
%
 
 
 
 
 
 
December 31, 2012:
 
 
 
 
 
Wells Fargo Securities, LLC (2)
$
1,956

 
28
 
1.46
%
 
(1)
Equal to the estimated fair value of securities or loans sold, plus accrued interest income, minus the sum of repurchase agreement liabilities plus accrued interest expense.
(2)
$16.8 million and $3.5 million of linked repurchase agreement borrowings are being included as derivative instruments as of March 31, 2013 and December 31, 2012.     
Resource Capital Corp [Member] | Repurchase Agreements [Member] | Deutsche Bank Securities, Inc [Member]
 
Debt Instrument [Line Items]  
Schedule of Amount at Risk under Credit Facility
The following table shows information about the amount at risk under this facility (dollars in thousands);
 
Amount at
Risk (1)
 
Weighted
Average
Maturity in Days
 
Weighted
Average
Interest Rate
March 31, 2013:
 
 
 
 
 
Deutsche Bank Securities, Inc.
$
5,360

 
15
 
1.28
%
 
 
 
 
 
 
December 31, 2012:
 
 
 
 
 
Deutsche Bank Securities, Inc.
$
2,069

 
7
 
1.46
%
 
(1)
Equal to the estimated fair value of securities or loans sold, plus accrued interest income, minus the sum of repurchase agreement liabilities plus accrued interest expense.